








































, António E. Nardi
2
 and Sérgio Machado
2,3 
1Polytechnic Institute of Porto, Health School, Porto, Portugal; 2Laboratory of Panic & Respiration (LABPR), Institute 
of Psychiatry (IPUB), Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil; 3Physical Activity Neurosci-
ence Laboratory, Physical Activity Sciences Postgraduate Program - Salgado de Oliveira University (UNIVERSO),  
Niterói, Brazil 
 
A R T I C L E  H I S T O R Y 
Received: December 16, 2015 
Revised: December 05, 2016 




Abstract: Background: Cognitive impairment is a major manifestation of schizophrenia and a crucial 
treatment target as these deficits are closely related to patients’ functional outcomes. Cognitive reme-
diation is the gold-standard practice to address cognitive deficits in schizophrenia. There is clear evi-
dence stating that cognitive remediation improves cognitive function and promotes structural neuro-
plastic changes in patients with schizophrenia, with brain-derived neurotrophic factor (BDNF) expres-
sion emerging as a potential biomarker for its efficacy. This is particularly important as there is clear 
evidence relating atypical BDNF expression to cognitive impairment in patients with schizophrenia. 
Despite the valuable role of cognitive remediation in the management of schizophrenia, there is still a 
need to develop methods that allow maximizing its efficacy.  
Method and Results: In this review, we present a hypothesis arguing that cognitive remediation effi-
cacy for patients with schizophrenia can be enhanced by aerobic exercise-induced BDNF upregulation. 
There have been a few trials reporting that combining aerobic exercise with cognitive training was su-
perior to cognitive training alone to improve cognitive functioning in patients with schizophrenia. Fur-
thermore, there is preliminary evidence suggesting that combined aerobic and cognitive training can 
increase peripheral BDNF levels.  
Conclusion: Thereby, engaging in aerobic exercise in close temporal proximity to cognitive remedia-
tion may allow achieving a state of neuroplastic readiness in the brain, facilitating cognitive function-
ing enhancement. Although this hypothesis still lacks evidence, future clinical trials using cognitive 
remediation for schizophrenia should explore strategies to maximize neuroplasticity and achieve opti-
mal cognitive improvements. 
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1. INTRODUCTION 
 Cognitive impairment is a major manifestation of schizo-
phrenia and a crucial treatment target as these deficits are 
closely related to patients’ functional and vocational out-
comes [1-5]. Although cognitive functioning is widely het-
erogeneous in this population [2, 6], cognitive impairment is 
observed in the majority of patients, even prior to disease 
onset [7, 8]. Patients with schizophrenia experience global 
cognitive dysfunction but deficits are mainly observed in 
working memory, executive function, attention, verbal and 
visual memory/learning and processing speed [9] as well as 
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in social cognitive skills such as theory of mind and emotion 
perception [10]. 
 Pharmacological interventions have been fairly modest 
addressing cognitive impairments [11, 12]. Therefore, alter-
native interventions such as cognitive remediation have been 
presented as promising tools to target cognitive functioning 
[13]. Cognitive remediation has been defined by the Cogni-
tive Remediation Experts Workshop has an intervention tar-
geting cognitive deficits (e.g. attention, memory, executive 
function, social cognition) using the scientific principles of 
learning with the ultimate goal of improving functional out-
comes [14]. However, although the final goal of cognitive 
remediation is functional improvement, it also aims to reduce 
the cognitive deficits detected by standardized tests [15]. 
Several meta-analyses have described significant effects of 
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cognitive remediation on cognitive performance of patients 
with schizophrenia [16-18]. A recent meta-analysis found 
small to moderate effects of cognitive remediation on cogni-
tive outcomes immediately after the intervention and on the 
follow-up assessments of patients with schizophrenia [19]. 
Furthermore, there has been evidence supporting the effects 
of cognitive remediation on social cognition, with significant 
positive effects reported regarding theory of mind and emo-
tion perception deficits [20, 21]. 
 The underlying theoretical framework for cognitive 
remediation is the cognitive neuroscience basis of learning, 
which assumes that at any point throughout the lifespan, 
brain capacity can be restored through neuroplasticity and 
neurogenesis [15, 22, 23]. Thereby, cognitive remediation 
provides a proper stimulating environment to harness the 
brain’s plastic ability, inducing neural changes that may al-
low  to improve cognitive functioning. Currently, there have 
been several molecular, functional and structural neuroimag-
ing studies reporting brain changes following cognitive 
remediation, providing evidence for its biological validity 
[13, 24, 25]. Thereby, cognitive remediation seems to acti-
vate neuroplastic and brain repair mechanisms, although 
researchers have not been able to pinpoint the underlying 
neurobiological processes. 
 Brain-derived neurotrophic factor (BDNF) is a well-
known neurotrophin that has been proposed as a possible 
biomarker for cognitive enhancement in schizophrenia [26, 
27]. BDNF has been linked to neurodevelopment and neuro-
protection of the central nervous system, playing a critical 
role in synapse regulation, learning, and memory [28, 29]. Its 
role on neuroplastic processes is associated with axonal and 
dendritic growth and remodeling, neuronal differentiation, 
synaptic transmission and growth [30, 31]. The neural dys-
function observed in psychiatric disorders such as schizo-
phrenia has been related to impaired cortical circuitry and 
synaptic transmission, which could be caused by changes in 
neurotrophins synthesis and/or expression. [32]. This hy-
pothesis is closely related to the contribution of BDNF to 
cognitive enhancement. Furthermore, there is also clear evi-
dence stating that exercise can improve cognitive function 
[33-36] and increase blood BDNF levels both in healthy sub-
jects and clinical populations [37], which lead several re-
searchers to explore the effects of combining cognitive 
remediation with exercise for several populations [38-41]. 
 Thereby, how can cognitive remediation and exercise be 
combined to maximize their effects on cognitive perform-
ance of schizophrenia patients? And can BDNF play a criti-
cal role in enhancing the effects of cognitive remediation? 
This report aims to present evidence that supports the follow-
ing hypothesis: aerobic exercise preceding cognitive reme-
diation can increase its effectiveness in patients with schizo-
phrenia by inducing a neuroplastic readiness state through 
BDNF levels increase. 
2. NEURAL CORRELATES OF COGNITIVE REME-
DIATION IN SCHIZOPHRENIA 
 Brain changes following cognitive remediation in pa-
tients with schizophrenia have been widely supported in the 
last decade. There are several systematic reviews addressing 
the neural and biological correlates of cognitive improve-
ments following cognitive remediation in these patients [13, 
24, 25]. Recently, Wei et al. [42] performed an activation 
likelihood estimation meta-analysis of functional magnetic 
resonance imaging (fMRI) and positron emission tomogra-
phy studies and found that cognitive remediation might im-
prove cognition in patients with schizophrenia by signifi-
cantly enhancing brain activation in several regions from the 
frontal and parietal cortex. Another systematic review of 
studies targeting social cognitive deficits suggests that cogni-
tive remediation is associated with a wide range of functional 
and structural changes in the social brain, namely prefrontal 
regions, the limbic system and perceptual areas [43].  
 The mostly explored method to study the neuroplastic 
effects of cognitive remediation in schizophrenia has been 
fMRI, with most studies highlighting its effects on the pre-
frontal cortex (PFC); [44-49]. Further evidence supporting 
the role of the PFC in cognitive remediation has been pro-
vided by Pu et al. [50] using near-infrared spectroscopy, 
founding increased activity in bilateral dorsolateral PFC, 
ventrolateral PFC and right frontopolar PFC after a com-
puter-based cognitive remediation intervention. Additionally, 
there was also evidence of increased activity after cognitive 
remediation in several brain regions crucial to cognitive 
function such as the occipital lobe, inferior and superior pa-
rietal cortex, cingulate cortex, among other [44, 45, 51]. 
Studies exploring brain activity changes following cognitive 
remediation interventions that target social cognitive deficits 
have also found interesting findings. For instance, Hooker et 
al. [52, 53] found increased neural activity after training in 
the bilateral amygdala, right putamen, right medial prefrontal 
cortex and postcentral gyrus, with improvements predicting 
performance on emotion processing measures. 
 Beyond the evidence of fMRI studies, there are also sev-
eral reports from electrophysiological studies (electroen-
cephalography and event-related potentials) that report nor-
malization of early perceptual processes and cognitive func-
tioning [54-56]. There are also reports of increased effi-
ciency in facial emotion processing after cognitive remedia-
tion targeting social cognition [57, 58].  
 Finally, there are also a few studies reporting morpho-
logical changes after cognitive remediation. Eack et al. [59] 
designed a 2-year cognitive remediation trial that was able to 
achieve structural changes in the brain of patients with schizo-
phrenia, allowing a significant gray matter volume increase in 
the left amygdala and inhibiting the progressive loss of gray 
matter in the left parahippocampal and fusiform gyrus in 
comparison to the control condition. Moreover, these effects 
on gray matter volume were remarkably associated with im-
proved social cognitive functioning. A study using diffusion 
tensor imaging also found increased fractional anisotropy 
after cognitive remediation in the body and genu of the cor-
pus callosum and right posterior thalamic radiations, whereas 
the active control group exhibited decreased fractional ani-
sotropy in the bilateral superior longitudinal fasciculus and 
left inferior longitudinal fasciculus [60]. 
 Summing it up, there is evidence from both functional 
and structural imaging procedures as well as from electro-
physiological studies supporting the role of cognitive reme-
diation in the neuroprotection and prevention of progressive 
neurodegeneration in schizophrenia. More importantly, the 
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reported neural correlates of cognitive remediation are 
clearly related to cognitive improvements after the interven-
tion. However, it is important to understand the neurobi-
ological pathways that may underlie these changes and sup-
port cognitive function in patients with schizophrenia, allow-
ing researchers and clinicians to develop intervention proto-
cols that maximize treatment effects for this population. 
3. BDNF AS A BIOMARKER FOR COGNITIVE  
REMEDIATION EFFECTIVENESS  
 In the last few years, BDNF has emerged as a potential 
candidate to explain the neuroplastic changes observed fol-
lowing cognitive remediation. There are several reviews ex-
ploring the role of BDNF in the cellular and molecular 
mechanisms which underlie cognitive functioning, especially 
learning and memory [28, 61, 62]. BDNF secretion is re-
quired for long-term potentiation and long-term depression 
as well as for cellular plasticity mechanisms that underlie learn-
ing and memory. Furthermore, BDNF overexpression can 
increase the number of dendritic spines or enhance dendritic 
complexity in specific brain tissues, making it an important 
contributor to hippocampal-dependent learning [63, 64]. 
 Several animal studies explored the effects of genetically 
or virally induced BDNF ablation on mice, reporting im-
pairments in various cognitive functions, mainly hippocam-
pal-dependent tasks such as context-dependent memory [65], 
spatial learning and novel object recognition [66, 67], but also 
in PFC-related functions such as spatial memory reversal and 
contextual memory extinction [68]. In contrast, transgenic 
overexpression of BDNF in the hippocampus and cerebral 
cortex enhanced learning and memory in a water maze task 
[69]. Furthermore, striatal BDNF infusions improved cogni-
tive flexibility (discrimination learning and strategy shifting) 
in rats [70]. 
 BDNF gene expression also seems to play a critical role 
in human cognitive functioning and its underlying brain re-
gions, namely the hippocampus and prefrontal regions [71]. 
The functional BDNFval66met polymorphism has been as-
sociated with abnormal intracellular trafficking and activity-
dependent secretion of BDNF, leading to impaired memory 
and hippocampal dysfunction [72]. Furthermore, Hariri et al. 
[73] reported that the interaction between this genotype and 
hippocampal response during encoding significantly ac-
counted for recognition memory performance. Evidence 
from both healthy and clinical populations also suggests that 
functional BDNF polymorphisms can be associated with 
changes in executive functioning [74-76]. 
 As evidence regarding the role of BNDF on learning and 
memory consolidated, researchers postulated that this protein 
could mediate the cognitive improvements achieved by cog-
nitive remediation. Animal studies using enriched environ-
ments that simulate cognitive stimulation have explored 
whether this intervention can modulate BDNF in the brain. 
Exposing animals to enriched environments has been associ-
ated with BDNF enhancement in several brain regions in-
cluding the cerebral cortex, basal forebrain, and hindbrain 
[77] as well as the cerebellum [78]. However, the most con-
sistent increases have been reported in the hippocampus [77, 
79-81]. Falkenberg et al. [82] actually reported a correlation 
between improved spatial memory and increased BDNF 
mRNA in rats’ hippocampus after exposing them to an en-
riched environment. There is also recent evidence suggesting 
that BDNF plays an intrinsic role in enhanced plasticity and 
memory following enriched environment exposure [79] as 
well as in experience-dependent plasticity related to auditory 
stimuli [83]. 
 More recently, there has been evidence from human stud-
ies with several clinical populations suggesting that BDNF 
may be one of the neurobiological correlates of cognitive 
remediation (Table 1). Angelucci et al. [27] applied a 12-
session executive functioning training program to patients 
with Parkinson’s disease with mild cognitive impairment and 
found significant increases in serum BDNF levels after the 
intervention in comparison to the placebo group, although 
there were no significant correlations between BDNF in-
crease and cognitive improvement. A recent study from Ca-
soli et al. [84] with subjects with mild cognitive impairment 
investigated the changes in BDNF mRNA level of peripheral 
lymphocytes after a 10-session cognitive training protocol. 
Interestingly, the cognitive training group experienced a de-
crease in BDNF mRNA. The authors argued that a compen-
satory mechanism may increase BDNF levels in mild cogni-
tive impairment and cognitive training may allow to restore 
pre-morbid levels. Finally, Pressler et al. [85] designed a 
trial with patients with heart failure using a computerized 
cognitive training program that targeted auditory information 
encoding, recall, and manipulation. After 8-weeks of inter-
vention with 5 sessions per week, participants assigned to the 
training program presented improved working memory and 
decreased decline in processing speed. Moreover, serum 
BDNF levels significantly increase in the experimental group 
in comparison to the control group.  
 There are also a few reports addressing the relationship 
between BDNF and cognitive remediation in patients with 
schizophrenia. Vinogradov et al. [26] and Adcock et al. [54] 
applied a 10-week computer-based auditory training program 
to 56 patients with chronic schizophrenia and found im-
provements in verbal working memory, immediate verbal 
learning, and verbal memory. More importantly, there was a 
significant increase in BDNF levels in comparison to the 
control group. There was no significant relationship between 
increased BDNF and improved cognitive scores, although a 
significant positive association with enhanced quality of life 
was reported. A subsequent report from the same team with 
an enlarged sample still provided evidence of cognitive im-
provement and BDNF increase after the intervention. Effect 
size analysis actually showed moderate training effects on 
BDNF levels since week 2 that remained around the same 
magnitude until the end of the intervention [86]. 
 Another cognitive remediation trial explored whether 
functional BDNF val66met polymorphism predicted treat-
ment response to a 16-session computerized cognitive reme-
diation program for paranoid schizophrenia [87]. There was 
no significant evidence supporting the role of the polymor-
phism as a prognostic factor for cognitive remediation but 
quite interestingly the participants with the BDNF val66met 
genotype were assigned to exercises with a lower degree of 
difficulty by the cognitive training software in the beginning 
of the intervention. 
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Table 1. Studies assessing BDNF changes after cognitive remediation. 











Major Findings  
Adcock et al. 
(2009) 
Vinogradov  










Computer games 10 weeks 
5 sessions/week 
1 hour/session 
Serum BDNF ↑ Serum BDNF levels 2 and 10 
weeks after CR in comparison to 
CG. 
Association between BDNF 
increase and quality of life 
improvements 
Casoli et al. 
(2009) 
Mild cognitive 













in peripheral  
lymphocytes 
↓ BDNF mRNA levels in the CR 
but not in the CG after the inter-
vention. 
















Genotypes did not predict cogni-
tive improvement; 
Polymorphism val/met was 
associated with lower scores 
(easier exercises) during train-
ing. 
Pressler et al. 
(2015) 





tive training (auditory 
training) 






↑ Serum BDNF levels in CR 
after training and 
↓ Serum BDNF levels in CG 
after the intervention regardless 
of BDNF val/met polymorphism 






Pen & pencil cognitive 










Serum BDNF ↑ BDNF serum levels in the CR 
but not in the CG after the inter-
vention 









Computer games Computerized 
auditory training 
Serum BDNF ↑ Serum BDNF levels 2 and 10 
weeks after CR in comparison to 
CG. 
No association between BDNF 
increase and cognitive improve-
ment. 
CR: cognitive remediation group; CG: control group. 
 
 The relationship between BDNF, cognition, and learning 
is quite well established in both animals and humans. 
Moreover, although evidence it not very robust, preliminary 
findings from human studies seem to support the hypothesis 
that BDNF is a biomarker of cognitive remediation efficacy.  
4. BDNF AND COGNITIVE IMPAIRMENT IN SCHI-
ZOPHRENIA 
 As evidence supporting the role of BDNF in cognitive 
enhancement increases, it becomes important to understand 
how this neurotrophin engages in the brain of patients with 
schizophrenia and its role on cognitive impairment. How-
ever, it is important to highlight that understating the asso-
ciation between BDNF and schizophrenia is quite hard as 
there are several potential confounders such as medication 
side-effects, phenotype, symptom severity and duration [88]. 
 Evidence regarding the role of BDNF in schizophrenia 
psychopathology comes from several fields of study. Genetic 
studies have associated functional BDNF polymorphisms 
(Val66Met and C-207T9) to increased susceptibility to schi-
zophrenia [89]. A meta-analysis developed by Jönsson et al. 
[90] with Caucasian individuals from the US and several 
European countries actually found an association between 
both functional polymorphisms and the presence of schizo-
phrenia. However, other meta-analyses have reported that 
this association cannot be found in Asian populations [91, 
92]. 
 Other studies actually explore the association between 
BDNF polymorphisms and cognitive deficits of patients with 
schizophrenia. Val66Met polymorphism has been associated 
with deficits in executive function and memory [93, 94], 
impaired visuospatial/constructional performance and atten-
tional decrements in male patients with schizophrenia [95]. 
Rybakowski et al. [96] did not found a relationship between 
Val66Met polymorphism and executive functioning, al-
though patients with Val/Val genotype had a superior work-
ing memory performance. Further evidence of disease-
specific Val66Met polymorphism involvement in schizo-
phrenia brain dysfunction has been supplied by a positron 
emission tomography study that reported significantly less 
hippocampal regional cerebral blood flow in patients harbor-
ing a Metallele, while there were no significant associations 
in healthy controls [97]. 
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 Although way scarce when compared to evidence from 
genetic studies, the role of BDNF in schizophrenia has also 
been supported by postmortem studies. Durany et al. [98] 
found increased BNDF concentrations in several cortical 
regions and a decrease in hippocampal tissues, although 
other authors actually found increased levels in the hippo-
campus [99]. However, there have been several studies de-
scribing reduced BDNF levels in prefrontal regions of pa-
tients with schizophrenia [100-102]. 
 The most commonly used approach to study the role of 
BDNF in schizophrenia has been the measurement of 
plasma/serum levels, allowing to understand if BNDF con-
centration fluctuates across the clinical evolution of the dis-
ease [93]. A meta-analysis by Green et al. [103] concluded 
that blood levels of BDNF are reduced in medicated and 
drug-naive patients with schizophrenia. More recently, a new 
meta-analysis also found that peripheral BDNF levels were 
moderately reduced in schizophrenia in comparison to con-
trol subjects, with concentration decreasing as disease dura-
tion increased [104]. However, it is important to highlight 
that there is a significant heterogeneity across study results 
as several authors did not found any differences in peripheral 
BDNF levels [105-107] and some even found higher levels 
in patients [108].  
 More importantly, there have been efforts to understand 
the association between BDNF levels and cognitive perform-
ance in schizophrenia. BDNF serum levels have been posi-
tively associated with immediate memory [95] and other 
cognitive tests [109]. Carlino et al. [110] found that reduced 
serum truncated-BDNF/total BDNF ratio correlated with 
poorer performance on processing speed, attention, executive 
function, and working memory. Moreover, it seems that de-
creased BDNF serum levels and cognitive impairment in 
schizophrenia are dependent on the BDNFVal66Met poly-
morphism [95]. More recently, Zhang et al. [111] described 
an association between BDNF levels, immediate memory, 
and global cognitive functioning only in female patients, 
suggesting a possible mechanism underlying gender-related 
differences in cognitive impairment in schizophrenia. 
 There is also evidence describing the positive association 
between plasma BDNF and several cognitive domains in 
first-episode psychosis patients, including learning ability, 
immediate and delayed memory, abstract thinking and proc-
essing speed, even after controlling for medication, IQ, drug 
use and negative symptoms [112]. BDNF seems to play a role 
in the course and onset of schizophrenia as there is an associa-
tion between low serum BDNF levels and reduced hippocam-
pal volume in first-episode drug-naive patients [113]. 
 Although researchers are far from understanding the 
mechanisms that underlie BDNF changes in schizophrenia, it 
is safe to state that this neurotrophin is implicated in the 
pathophysiology of schizophrenia. Furthermore, BDNF 
seems an important candidate to help us understand the mo-
lecular and cellular mechanisms that underlie cognitive im-
pairment in individuals with schizophrenia [93]. 
5. EXERCISE-INDUCED COGNITIVE AND BDNF  
ENHANCEMENT IN SCHIZHOPHRENIA 
 BDNF may be a critical biological footprint of cognitive 
impairment in schizophrenia, which led researchers to ex-
plore interventions that could modulate its expression in the 
brain. Although cognitive remediation is a highly effective 
tool for cognitive enhancement and has been associated with 
BDNF levels increase, exercise has also shown promising 
results to improve cognitive performance and brain function 
in patients with schizophrenia (Table 2), [114-116]. Zwick  
et al. [117] reported that exercise was effective to improve 
working memory, short-term memory and verbal learning in 
patients with paranoid schizophrenia. Falkai et al. [118] ap-
plied a cycling aerobic exercise protocol for 3 months and 
found enhanced short-term memory in comparison to an ac-
tive control intervention. More recently, a pre-experimental 
study using high-velocity resistance circuit for chronic pa-
tients also found significant intervention effects on process-
ing speed and working memory [119]. 
 It seems that exercise enhances memory and learning in 
patients with schizophrenia, but it is also important to high-
light that a few trials have also explored the neural correlates 
that support these improvements. The first major findings 
regarding exercise-induced neuroplastic changes in schizo-
phrenia were reported by Pajonk et al. [120], who found in-
creased hippocampal volume after 3 months of aerobic exer-
cise in chronic patients. Interestingly, subsequent analysis 
explored whether aerobic exercise also induced neocortical 
changes but found no significant effects in gray matter den-
sity and cortical expansion across the whole cortex [118]. 
This may suggest specific exercise effects on the hippocam-
pus, although other authors have found no changes in hippo-
campal volume after a 6-month multimodal aerobic exercise 
program [121]. A recent study using diffusion tension imag-
ing found very significant treatment effects after a 6-month 
bicycle ergometer aerobic exercise protocol, improving the 
integrity of white matter fiber tracts, while participants in the 
active control group experienced decreased fiber integrity 
[122]. These findings were mainly prominent in motor func-
tioning related tracts (corticospinal tract and superior longi-
tudinal fascicle) but findings on the inferior longitudinal fas-
cicle, inferior fronto-occipital fascicle, and anterior thalamic 
radiation may also suggest improved efficiency in cognitive 
functions such as attention, visual and verbal processing, 
executive function and memory encoding. 
 The potential of exercise for cognitive improvement in 
patients with schizophrenia is quite clear and researchers are 
getting increasingly closer to the neural correlates that sup-
port these changes. But could it be that exercise shares the 
same neurobiological mechanisms that support cognitive 
enhancement in cognitive remediation? Can neurotrophic 
factors such as BDNF be mediators of exercise-induced cog-
nitive effects? 
 Although several mechanisms have been proposed to 
debate exercise-induced cognitive improvement, in the last 
decade researchers developed numerous studies to under-
stand the relationship between BDNF, exercise, and cogni-
tive functioning. Neeper et al. [123] were the first to report 
that physical activity could increase BDNF levels in the rat’s 
brains by upregulating its expression the hippocampus and 
caudal neocortex. Further evidence from animal studies sug-
gests that the potential benefits of exercise on cognitive func-
tion are inhibited when BDNF action in the hippocampus is 
blocked [124]. 
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Table 2. Exercise-induced cognitive and neuroplastic changes in schizophrenia. 








Major Findings  
Pajonk et al. 
(2010) 















↑ Hippocampal volume in the EG 
(12%) in comparison to the CG 
(−1%); 
Correlation between hippocampal 
volume changes and improvements 
VO2max/kg and maximum power 
per kilogram (r=0.72; r=0.83). 






No info 4 sessions/week 
30 min/session 
No info Occupational 
Therapy 
↑ Working memory, short term 
memory and verbal learning in the 
EG in comparison to the CG 

















↑ Short-term memory in the EG after 
exercise; 
No significant changes in gray matter 
density and cortical expansion. 
Takahashi  
et al. (2012) 












RPE 11-13 Treatment as 
usual 
↑ Activation in the extrastriate body 
area f the posterior temporal-
occipital cortex was observed in the 
EG after exercise. 











40 min aerobic 









tory fitness (peak work rate at ex-
haustion) improvement and cerebral 
matter volume increase as well as 
lateral and third ventricle volume 
decrease. 












25 min aerobic 














↑ Serum BDNF values only in the 
EG. 
Kimhy et al. 
(2015) 


















↑ Overall neurocognitive functioning 
in the EG (15.1%) in comparison to 
the CG (-2.0%); 
↑ Serum BDNF levels in the EG 
(11.1%) in comparison to the CG 
(1.9%); 
BDNF changes contributed 14.6% to 
neurocognitive improvement after 
training. 










 2 sessions/week 
Increase loading 
across training 
based on max 
power production 
None ↑ Global cognitive functioning, 
speed of processing and working 
memory after training. 












40 min aerobic 
exercise plus 20 min 
strength exer-
cises/session  
No info Occupational 
therapy 
↑ Fractional anisotropy in the left 
corticospinal tract, left superior 
longitudinal fascicle and forceps 
major of corpus callosum in the EG 
in comparison to the CG. 
SZ: schizophrenia; EG: exercise group; CG: control group; VO2max/kg: maximum oxygen consumption per kilogram; RPE: rating of perceived exertion; HRR: heart rate reserve; 
HRmax: maximal heart rate.
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 In human studies, evidence regarding enhanced BDNF 
levels after aerobic exercise has been pretty well-established 
by several systematic reviews [37, 125, 126]. A recent meta-
analysis explored the effects of exercise on BDNF expres-
sion across healthy subjects and clinical populations, with 
findings proving reliable evidence that both acute and regu-
lar exercise can increase peripheral BDNF levels [37]. More 
precisely, moderate effects were found on BDNF levels after 
a single session of acute exercise. Chronic regular exercise 
was associated with small effects in resting BDNF levels and 
a moderate effect in single bout exercise-induced BDNF 
increase after the completion of training programs. 
 It is important to highlight that there are several studies 
with neuropsychiatric disorders reporting exercise-induced 
BDNF increase, including depression [127-129], panic dis-
order [130], mild cognitive impairment [131] and Alz-
heimer’s disease [132]. Kim et al. [133] were the first to 
report the effects of exercise on peripheral BDNF levels in a 
sample of 86 patients with schizophrenia. After a 3-month 
protocol of combined strength and aerobic exercise, serum 
BDNF levels significantly increased in comparison to the 
control group. More recently, Kimhy et al. [134] designed a 
randomized clinical trial to assess the effects of a 3-month 
aerobic exercise protocol for chronic patients in serum 
BDNF levels. Besides significant improvements in global 
cognitive functioning, the authors also reported a higher in-
crease in BDNF levels in the experimental group (11%) in 
comparison to the control group (1.9%). However, the major 
finding was the result of a hierarchical step-wise regression 
analysis that found that after controlling for a series of vari-
ables (e.g. age, gender, medication), changes in BDNF levels 
significantly accounted for 14.6% of the variance in cogni-
tive functioning. 
 Looking at all the pieces together, it is possible to under-
stand that exercise is a valuable tool for cognitive enhance-
ment in patients with schizophrenia and that there is prelimi-
nary evidence linking aerobic exercise, BDNF upregulation 
and cognitive improvement. 
6. PROMOTING COGNITIVE REMEDIATION THR-
OUGHT EXERCISE-INDUCED PLASTICITY 
 Looking at the previously described evidence there are 
several assumptions to highlight regarding cognitive reme-
diation and BDNF expression in schizophrenia: 
i). Cognitive remediation effectively improves cogni-
tive function and promotes functional and structural 
neuroplastic changes in patients with schizophrenia; 
ii). Evidence from genetic, post-mortem and neurobi-
ological studies noticeably indicate that BDNF ex-
pression is atypical in patients with schizophrenia, 
with clear evidence of reduced peripheral BDNF 
levels; 
iii). There is evidence suggesting that BDNF expression 
may be a biomarker of cognitive remediation in sev-
eral clinical populations, including schizophrenia. 
 Despite the valuable role of cognitive remediation in the 
management of schizophrenia, its effects are frequently 
modest and alternative methods to enhance its efficacy 
should be studied. Exercise has been growingly explored in 
schizophrenia as it seems to enhance cognitive performance, 
neural functioning, and neuroplastic processes through 
BDNF levels increase. Thereby, there is evidence suggesting 
that BDNF may be a biomarker for cognitive enhancement in 
both aerobic exercise and cognitive remediation. 
 Our hypothesis argues that cognitive remediation efficacy 
can be enhanced by aerobic exercise induced BDNF upregula-
tion (Fig. 1). To sustain this hypothesis, it’s important to no-
tice evidence from trials combining exercise plus cognitive 
training. A recent systematic review found that simultaneous 
or subsequently combined exercise and cognitive remedia-
tion seems to be more effective to improve cognitive func-
tioning that either intervention alone [135]. There have been 
several trials reporting that combined cognitive training and 
exercise is superior to either intervention alone to improve 
cognitive functioning in elderly participants, namely divided 
attention [136, 137], shifting attention and working memory 
[138], verbal memory [139], overall memory quotient [140], 
global cognitive performance and independent living measures 
[141]. 
 More recently, there have been a few trials exploring the 
combination of cognitive remediation and aerobic exercise in 
patients with schizophrenia. Oertel-Knochel et al. [142] 
compared 12 sessions of cognitive training combined with 
either aerobic exercise or relaxation training. The protocol 
lasted 4 weeks (3 sessions per week) and participants com-
pleted 30 minutes of multimodal cognitive training plus 45 
minutes of moderate-intensity aerobic exercise (60-70% 
maximum heart rate). Participants in the aerobic exercise 
plus cognitive training group displayed increased working 
memory improvement in comparison to the active control 
group. Another trial designed a 12-week aerobic exercise 
training protocol, with added cognitive training beginning in 
the 6th week of treatment [143]. First, participants completed 
30-minute sessions of aerobic exercise (3 times per week) 
and after 6 weeks, 30 minutes of computerized cognitive 
training (memory and attention) were added after the aerobic 
training period. The combined group had significant im-
provements in long and short-term verbal memory, cognitive 
flexibility, global and social functioning measures. Although 
there were no significant differences in improvements com-
pared to the cognitive training plus table soccer group, the 
functional outcomes changes were correlated with enhanced 
cognitive functioning only in the combined training group. 
Moreover, a subsequent report regarding the same protocol 
found increased volume in the left superior, middle and infe-
rior anterior temporal gyri after training [144]. Finally, a 
pilot study from Nuechterlein et al. [145] with first-episode 
schizophrenia patients engaged participants in combined 
aerobic exercise and cognitive training versus cognitive 
training alone. Over a 10 week period, participants com-
pleted 4 hours per week of cognitive training (neurocognitive 
plus social-cognitive exercises) and 150 minutes per week of 
aerobic exercise at 60-80% maximum heart rate (90 minutes 
in the clinic plus 60 minutes home-based). The combined 
intervention group was superior to the cognitive training 
alone on global cognition and independent living skills, with 
largest differential gains favoring the combined group on 
measures related to social cognition, working memory, proc-
essing speed and attention. 
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Fig. (1). Hypothesis of cognitive remediation efficacy enhancement for patients with schizophrenia through exercise-induced increase in 
BDNF levels. 
 
 Trials combining aerobic exercise with cognitive reme-
diation are increasing and it seems clear that adding the ef-
fects of both interventions may allow to improve cognitive 
functioning. Furthermore, there are also a few trials explor-
ing brain-related effects of combined exercise and cognitive 
remediation. Shah et al. [139] found an association between 
improved verbal memory and increased levels of cerebral 
glucose metabolism after a protocol of combined exercise 
and cognitive training for elderly participants. Combined 
training was associated with enhanced neural activity and 
BDNF could play a role in the detected changes, as there is 
evidence supporting the association between BDNF and glu-
cose metabolism modulation [146, 147]. Furthermore, there 
is also evidence suggesting that combined aerobic and cogni-
tive training can increase peripheral BDNF levels both in 
elderly participants [137] and in patients with schizophrenia 
[145]. 
 Although there is still a need for further research regard-
ing how BDNF mediates the interaction between exercise 
and cognitive remediation, the previously described findings 
contribute to our hypothesis, suggesting that exercise-
induced BDNF levels increase before cognitive training can 
maximize its efficacy in patients with schizophrenia. The 
rationale behind this hypothesis is similar to the assumptions 
that underlie exercise usage to promote motor rehabilitation 
in stroke. Some authors suggest that BDNF can optimize 
neuroplastic potential and facilitate motor learning [148] and 
cognitive improvement [149] in order to promote the reha-
bilitative process. It is clear that neuroplasticity is a corner-
stone of cognitive remediation and our hypothesis argues 
that exercise-induced plasticity, achieved by BDNF concen-
tration increase, can enhance gains after the intervention. 
More specifically, engaging in aerobic exercise in close tem-
poral proximity to cognitive remediation may allow achiev-
ing a state of neuroplastic readiness in the CNS [148, 150] as 
exercise-induced BDNF activity allows for a decrease in the 
threshold for successful encoding and memory [151]. This 
temporal closeness allows for the exercise-induced plastic 
effects to be more effectively harnessed during cognitive 
remediation, facilitating cognitive functioning enhancement 
[152]. 
 Thereby, as temporal closeness between aerobic exercise 
and cognitive remediation may be critical to harness their 
combined effects, it’s important to understand how BDNF 
levels fluctuate after a single bout of exercise. There is evi-
dence suggesting that increased peripheral neurotrophin lev-
els induced by exercise are incrementally cleared after exer-
cise [153]. There is even consistent evidence stating that 
peripheral BDNF levels decrease back to baseline concentra-
tion within 15-60 minutes after exercise, regardless of exer-
cise intensity [154]. Thereby, if cognitive remediation effi-
cacy can be potentiated by exercise-induced BDNF levels 
increase, there is a considerably short time window for pa-
tients with schizophrenia to complete cognitive remediation 
procedures after aerobic exercise.  
 Another important issue when addressing the proposed 
hypothesis is to understand how aerobic exercise intensity 
plays a role on BDNF expression in schizophrenia. There has 
been evidence suggesting that the magnitude of BDNF in-
crease is associated with exercise intensity [155, 156]. A 
systematic review from Knaepen et al. [154] including stud-
ies with healthy participants and patients with chronic dis-
eases suggested that to immediately increase peripheral 
BDNF concentration participants should perform bouts of 
acute exercise at 60% maximum heart rate. The literature  
is scarce regarding the role of exercise intensity on BDNF 
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expression in patients with schizophrenia but evidence from 
both healthy and clinical populations suggest that moderate 
intensity can be reliable to increase peripheral BDNF levels 
[37]. Future studies should explore exercise protocols with 
different intensities to further understand the relationship 
between exercise and BDNF levels in this population. 
 To further support the proposed hypothesis it is also im-
portant to understand whether exercise-induced BDNF 
upregulation clearly occurs in the brain, promoting the neu-
roplastic mechanisms that support cognitive remediation. 
BDNF expression is usually measured by serum or plasma 
levels but it is important to understand if peripheral BDNF 
increase correlates to enhanced brain expression of this neu-
rotrophin. BDNF release during exercise has been associated 
with several sources including platelets [stores most of the 
peripheral BDNF; 157] and skeletal muscle cells [BDNF is 
produced by these cells in response to contraction; 158]. 
However, Rasmussen et al. [159] findings suggest that the 
brain is the main provider of circulating BDNF after exer-
cise, contributing around 70-80% of total production. Fur-
thermore, although some authors argue that BDNF does not 
easily cross the blood-brain barrier (BBB); [160], there has 
evidence suggesting that BDNF in the peripheral circulation 
can cross the BBB by a high-capacity, saturable transport 
system [161, 162], a process which is likely enhanced after 
exercise as there is increased BBB permeability [163, 164]. 
Thereby, it seems that BDNF can cross the BBB bidirection-
ally, allowing to hypothesize that BDNF leaves the brain in 
order to be stored in other body regions or that peripheral 
BDNF is transported to the brain in order to promote neural 
health [165]. Either way, although the mechanisms of exer-
cise-induced BDNF expression are not perfectly understood, 
it seems that this neurotrophin is clearly related to brain neu-
roplasticity after exercise or at least an important indicator of 
enhanced neuroplastic activity. 
 Finally, it is also important to debate the practical impli-
cations of sequentially performing aerobic exercise plus cog-
nitive remediation. Adherence is a challenge for any inter-
vention targeting patients with schizophrenia. Moderate at-
tendance rates have been described in programs using aero-
bic exercise alone [166] and these values could be even 
lower in more demanding protocols such as combined exer-
cise and cognitive remediation. Most studies combining 
these interventions do not provide clear information regard-
ing the timeline between cognitive remediation and aerobic 
exercise sessions, but most of them seem to provide the in-
terventions on different days. Interestingly, in the study from 
Malchow et al. [143] participants actually completed cogni-
tive remediation right after the aerobic exercise period and 
had a positive adherence to the protocol. Only 3 participants 
dropped out of the study and the remaining 22 completed 
75% or more of the training sessions. Thereby, it seems fea-
sible to combine both interventions consecutively although 
future trials should explore resources to promote long-term 
protocol adherence. For instance, exergames have been used 
to engage patients with schizophrenia in physical activity 
[167, 168] and designing games that allow participants to 
accomplish both aerobic exercise and cognitive remediation 
may be an interesting resource to increase participant’s ad-
herence. Group based aerobic exercise may also be a valu-
able resource to engage patients with schizophrenia as social 
support plays a critical role in initiating and maintaining 
compliance to exercise [169]. 
 Finally, an alternative pathway to promote exercise-
induced neuroplasticity may be the long-term increase in 
BDNF levels achieved by regular exercise. A recent meta-
analysis reported that prolonged exercise programs ranging 
from 3 weeks to 2 years, with a frequency of 2 to 5 days per 
week were able to effectively increase resting peripheral 
BDNF levels [37]. Moreover, the authors also reported that 
when engaging in regular physical exercise, there is an in-
crease in neurotrophic activity that becomes gradually larger 
after each training session. Thereby, one can postulate that 
cognitive remediation efficacy for patients with schizophre-
nia may be enhanced if participants previously engage in 
aerobic exercise training, in order to create a state of neuro-
plastic readiness in the brain. There are no guidelines regard-
ing the frequency or duration needed in order to achieve 
brain plasticity benefits, but it seems reasonable to follow the 
international exercise recommendations which state that pa-
tients should do at least 150 minutes a week of moderate-
intensity, or 75 minutes of moderate- to vigorous-intensity 
aerobic activity [170, 171]. 
CONCLUSION 
 Cognitive remediation’s biological validity is clearly 
related to the structural and functional brain changes 
achieved through the neuroplasticity mechanisms that under-
lie learning and cognitive functioning improvements. Aero-
bic exercise may be an effective tool to enhance this plastic-
ity by up-regulating BDNF expression, a neurothopin which 
is directly involved in learning and memory. Thereby, the 
development of cognitive remediation sessions shortly after 
single bouts of aerobic exercise should allow for a neural 
environment that nurtures the efficacy on cognitive out-
comes. There is still a need to design high-quality clinical 
trials assessing the role of exercise intensity on BDNF levels 
increase in schizophrenia. Furthermore, it would be interest-
ing to understand if baseline BDNF levels predict cognitive 
remediation outcomes as there are no studies reporting this 
association. Finally, the temporal relationship when combin-
ing cognitive remediation and aerobic exercise should be 
explored, to understand the processes behind the cumulative 
effects of both interventions.  
 Cognitive deficits present a major burden for patients 
with schizophrenia and their families. Due to the inefficiency 
of pharmacological treatment in the treatment of these defi-
cits, enhancing the efficacy of cognitive remediation through 
exercise-induced plasticity can be an appealing and effective 
alternative. There are several factors that play of role on neu-
roplasticity such as demographic variables, clinical history, 
pharmacological treatment, genetic factors, among others. 
However, future clinical trials using cognitive remediation 
for schizophrenia should be designed to explore possible 
strategies to maximize neuroplasticity and, thereby, achieve 
optimal cognitive improvements. 
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